What Is HCM and Why Maine Coons Are at Elevated Risk
Hypertrophic cardiomyopathy (HCM) is the most common cardiac disease in domestic cats, affecting an estimated 15% of the general feline population. It is characterised by abnormal thickening (hypertrophy) of the left ventricular wall of the heart, which reduces the chamber's ability to fill with blood between beats. Over time, the heart compensates by beating faster and with greater force — a cycle that ultimately leads to heart failure, dangerous arrhythmias, and in some cases, sudden death.
Maine Coons are at substantially elevated risk due to a specific genetic mutation identified in the cardiac myosin binding protein C (MYBPC3) gene — designated the A31P mutation. This autosomal dominant mutation means a cat needs only one copy (from one parent) to be at risk of developing HCM. Research published in the Journal of Veterinary Internal Medicine indicates that approximately 30–34% of Maine Coons carry this mutation. Importantly, being a carrier does not guarantee the cat will develop clinical disease — penetrance is incomplete and variable — but it substantially increases lifetime risk compared to non-carriers.
Why HCM Is So Dangerous: The Symptom Problem
The reason HCM is so devastating in practice is that it is almost entirely asymptomatic until it becomes advanced. Unlike many diseases that give clear early warning signals, cats with moderate HCM often appear completely normal — normal energy, normal appetite, no obvious breathing difficulty. The first observable signs typically appear only when the disease has progressed to the point of congestive heart failure (fluid accumulation in or around the lungs) or when a blood clot has formed.
Aortic thromboembolism (ATE) — also called "saddle thrombus" — is one of the most feared complications of HCM in cats. Blood clots forming in the enlarged, turbulent left atrium can break off and lodge at the aortic trifurcation (where the aorta splits to supply the hind legs), causing sudden, severe hind limb paralysis, extreme pain, and cold back legs. This is a medical emergency with a guarded prognosis, and it is often the first sign of heart disease an owner ever sees — with no warning whatsoever. Regular echocardiographic screening is the only way to detect HCM before this point.
Screening: What Test You Need and How Often
A stethoscope examination is not sufficient to diagnose HCM. Many affected cats have no audible murmur, and a murmur does not confirm HCM — it only suggests further investigation is warranted. The gold standard diagnostic test is echocardiography (cardiac ultrasound), which directly visualises the heart wall thickness, chamber dimensions, and heart function in real time. This test must be performed by a veterinary cardiologist or an experienced internal medicine specialist with appropriate equipment.
Maine Coon owners should begin echocardiographic screening at 2 years of age and repeat every 18–24 months. Male Maine Coons are significantly more likely to develop HCM and to have more severe disease than females — males should be screened annually from age 3 onwards. A DNA test for the A31P MYBPC3 mutation is commercially available and can be performed on a cheek swab. A positive DNA test confirms elevated risk and should increase screening frequency; a negative test is reassuring but does not eliminate HCM risk entirely, as there are likely additional mutations not yet identified in the breed.
📋 Maine Coon HCM Screening Schedule
- 8–12 weeks: DNA test for MYBPC3 A31P mutation (optional but recommended)
- 2 years: First echocardiogram by a board-certified veterinary cardiologist
- 2–5 years (female): Echocardiogram every 24 months
- 3+ years (male): Echocardiogram every 12–18 months
- Any age: If sudden onset breathing difficulty, immediate emergency vet
- Any age: If sudden hind limb weakness or paralysis — emergency vet immediately
Management and Treatment: What Modern Cardiology Offers
There is currently no cure for HCM in cats — no medication or intervention reverses the structural changes to the heart wall. However, management can meaningfully extend quality of life and delay progression to end-stage disease. The cornerstone of treatment is clopidogrel (Plavix) — an antiplatelet agent that reduces the risk of blood clot formation and is strongly supported by the landmark FATCAT trial, which showed a 43% reduction in ATE recurrence and significantly longer survival in cats receiving clopidogrel versus aspirin.
For cats in congestive heart failure (with fluid in the lungs), furosemide (a diuretic) is used to remove excess fluid. Beta-blockers (atenolol) may slow heart rate and reduce oxygen demand. The appropriateness of each medication depends on the stage of disease and must be determined by a veterinary cardiologist based on echocardiographic measurements. Weight management is also important — obese cats with HCM progress faster than lean ones, and excess weight increases cardiac workload.
🚨 Emergency Signs of Cardiac Crisis — Go to an Emergency Vet Immediately
- Open-mouth breathing or breathing with obvious effort at rest
- Sudden hind limb paralysis, dragging back legs, or crying out in pain
- Blue or grey gums (cyanosis)
- Sudden collapse or loss of consciousness
- Extreme lethargy — cat unable or unwilling to move
- Rapid, visible chest movement at rest (laboured breathing)
Want the Complete Maine Coon Care Manual?
Full cardiac screening guides, feeding plans, grooming schedules for that magnificent coat, and breed-specific health timelines — all in one PDF.
Browse All Manuals →
